Loading...
Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides
[Image: see text] The application of class I HDAC inhibitors as cancer therapies is well established, but more recently their development for nononcological indications has increased. We report here on the generation of improved class I selective human HDAC inhibitors based on an ethylketone zinc bi...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Chemical
Society
2018
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466521/ https://ncbi.nlm.nih.gov/pubmed/30996783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00517 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|